Effect of rivastigmine on scopolamine-induced memory impairment in rats. (Q52030482)

20 April 2018

title

Effect of rivastigmine on scopolamine-induced memory impairment in rats. (English)

1 reference

20 April 2018

1 reference

Bejar C

1

1 reference

20 April 2018

Wang RH

series ordinal

2

1 reference

20 April 2018

Weinstock M

series ordinal

3

1 reference

20 April 2018

language of work or name

English

0 references

publication date

1 November 1999

1 reference

20 April 2018

European Journal of Pharmacology

published in

1 reference

20 April 2018

volume

383

1 reference

20 April 2018

issue

3

1 reference

20 April 2018

page(s)

231-240

1 reference

20 April 2018

Patterns of memory failure after scopolamine treatment: implications for cholinergic hypotheses of dementia

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900643-3

Neurotransmitter-related enzymes and indices of hypoxia in senile dementia and other abiotrophies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900643-3

An inverted U-shaped curve for heptylphysostigmine on radial maze performance in rats: comparison with other cholinesterase inhibitors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900643-3

Relationship between pharmacodynamic activity and cognitive effects of eptastigmine in patients with Alzheimer's disease. Eptastigmine Study Group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900643-3

Effects of four non-cholinergic cognitive enhancers in comparison with tacrine and galanthamine on scopolamine-induced amnesia in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900643-3

Dose-dependent CSF acetylcholinesterase inhibition by SDZ ENA 713 in Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900643-3

The behavioral effects of heptyl physostigmine, a new cholinesterase inhibitor, in tests of long-term and working memory in rodents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900643-3

A new and rapid colorimetric determination of acetylcholinesterase activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900643-3

Brain selective inhibition of acetylcholinesterase: a novel approach to therapy for Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900643-3

Memory retention: potentiation of cholinergic drug combinations in mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900643-3

Physostigmine, tacrine and metrifonate: the effect of multiple doses on acetylcholine metabolism in rat brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900643-3

Enzyme inhibiting action of tetrahydroaminoacridine and its structural fragments

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900643-3

A 30-week randomized controlled trial of high-dose tacrine in patients with Alzheimer's disease. The Tacrine Study Group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900643-3

Cholinergic 'blockade' as a model for cholinergic depletion. A comparison of the memory deficits with those of Alzheimer-type dementia and the alcoholic Korsakoff syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900643-3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900643-3

Involvement of hormonal and neuromodulatory systems in the regulation of memory storage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900643-3

Muscarinic receptors mediate attenuation of extracellular acetylcholine levels in rat cerebral cortex after cholinesterase inhibition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900643-3

Developments of a water-maze procedure for studying spatial learning in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900643-3

Correlation of brain levels of 9-amino-1,2,3,4-tetrahydroacridine (THA) with neurochemical and behavioral changes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900643-3

Tetrahydroaminoacridine alleviates medial septal lesion-induced and age-related spatial reference but not working memory deficits.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900643-3

Metrifonate improves spatial navigation and avoidance behavior in scopolamine-treated, medial septum-lesioned and aged rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900643-3

A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease. Donepezil Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900643-3

Effects of oral physostigmine in Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900643-3

Scopolamine impairs spatial maze performance in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900643-3

Cholinergic receptor blockade impairs spatial localization by use of distal cues in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900643-3

Characterization of a novel muscarinic receptor agonist, YM796: comparison with cholinesterase inhibitors in in vivo pharmacological studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900643-3

Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900643-3

Antiamnesic and cholinomimetic side-effects of the cholinesterase inhibitors, physostigmine, tacrine and NIK-247 in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900643-3

Working and reference memory in rats in the three-panel runway task following dorsal hippocampal lesions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900643-3

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0014-2999(99)00643-3

1 reference

20 April 2018

PubMed ID

10594314

1 reference

20 April 2018